Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MAGE-A4-Responsive Plasma Cells Promote Non-Small Cell Lung Cancer.
Armstrong D, Chang CY, Hong MJ, Green L, Hudson W, Shen Y, Song LZ, Jammi S, Casal B, Creighton CJ, Carisey A, Zhang XH, McKenna NJ, Kang SW, Lee HS, Corry DB, Kheradmand F. Armstrong D, et al. Among authors: lee hs. bioRxiv [Preprint]. 2024 Jul 16:2024.07.10.602985. doi: 10.1101/2024.07.10.602985. bioRxiv. 2024. PMID: 39071307 Free PMC article. Preprint.
Skewed adaptive immune responses are involved in AATD emphysema.
Rojas-Quintero J, Ochsner SA, Lee HS, Cong C, Cohen AW, Colborg AS, Tsoyi K, Basil MC, Cantu E, Rosas IO, McKenna NJ, Estépar RS, Barjaktarevic I, Wilson AA, Polverino F. Rojas-Quintero J, et al. Among authors: lee hs. Eur Respir J. 2024 Oct 10:2400839. doi: 10.1183/13993003.00839-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39401853 No abstract available.
Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors.
Espinosa-Carrasco G, Scrivo A, Zumbo P, Dave A, Betel D, Hellmann M, Burt BM, Lee HS, Schietinger A. Espinosa-Carrasco G, et al. Among authors: lee hs. bioRxiv [Preprint]. 2023 Jul 3:2023.07.03.547423. doi: 10.1101/2023.07.03.547423. bioRxiv. 2023. Update in: Cancer Cell. 2024 Jul 8;42(7):1202-1216.e8. doi: 10.1016/j.ccell.2024.05.025. PMID: 37461721 Free PMC article. Updated. Preprint.
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.
Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, Pérez Valdivia MA, Wu MS, Susan Huang SH, Alamartine E, Kim SG, Yee M, Kateifides A, Rice K, Garlo K, Barratt J; SANCTUARY Study Investigators. Lafayette R, et al. J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000534. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39455063 No abstract available.
9,420 results